Stem Cells International / 2019 / Article / Fig 5

Research Article

Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice

Figure 5

hUC-MSC treatment affects T and B cell compartments in PCOS mice. Flow cytometry results of T and B cells in the peripheral blood and spleen. (a) The percentage of peripheral and splenic T cells (CD3+), T helper cells (CD3+CD4+), and cytotoxic T cells (CD3+CD8+). (b) The percentage of splenic IFN-γ+T helper cells (Th1). (c) The percentage of splenic IL-17+T helper cells (Th17). (d) The percentage of splenic IL-4+T helper cells (Th2). (e) The percentage of peripheral and splenic Tregs (CD4+CD25+). (f) The percentage of peripheral and splenic B cells (CD19+). (g) The percentage of splenic IFN-γ+CD19+B cells. -10 per group. Values are expressed as the . and .
(a)
(b)
(c)
(d)
(e)
(f)
(g)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.